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Propensity of red blood cells to undergo P2X7 receptor-mediated 
phosphatidylserine exposure does not alter during in vivo or ex vivo aging 
Abstract 
Phosphatidylserine (PS) exposure facilitates the removal of red blood cells (RBCs) from the circulation, 
potentially contributing to the loss of stored RBCs after transfusion, as well as senescent RBCs. 
Activation of the P2X7 receptor by extracellular adenosine 5′-triphosphate (ATP) can induce PS exposure 
on freshly isolated human RBCs, but whether this process occurs in stored RBCs or changes during RBC 
aging is unknown. STUDY DESIGN AND METHODS RBCs were processed and stored according to 
Australian blood banking guidelines. PS exposure was determined by annexin V binding and flow 
cytometry. Efficacy of P2X antagonists was assessed by flow cytometric measurements of ATP-induced 
ethidium+ uptake in RPMI 8226 cells. Osmotic fragility was assessed by lysis in hypotonic saline. RBCs 
were fractionated by discontinuous density centrifugation. RESULTS ATP (1 mmol/L) induced PS 
exposure on RBCs stored for less than 1 week. This process was near-completely inhibited by the P2X7 
antagonists A438079 and AZ10606120 and the P2X1/P2X7 antagonist MRS2159 but not the P2X1 
antagonist NF499. ATP-induced PS exposure on RBCs was not dependent on K+, Na+, or Cl− fluxes. ATP 
did not alter the osmotic fragility of stored RBCs. ATP-induced PS exposure was similar between RBCs of 
different densities. ATP-induced PS exposure was also similar between RBCs stored for less than 1 week 
or for 6 weeks. CONCLUSION The propensity of RBCs to undergo P2X7-mediated PS exposure does not 
alter during in vivo and ex vivo aging. Thus, P2X7 activation is unlikely to be involved in the removal of 
senescent RBCs or stored RBCs after transfusion. 
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ABSTRACT	  
BACKGROUND:	   Phosphatidylserine	   (PS)	   exposure	   facilitates	   the	   removal	   of	   RBCs	   from	   the	  
circulation,	  potentially	  contributing	  to	  the	  loss	  of	  stored	  RBCs	  following	  transfusion,	  as	  well	  as	  
senescent	  RBCs.	  Activation	  of	   the	  P2X7	   receptor	   by	   extracellular	   adenosine	  5’-­‐triphosphate	  
(ATP)	   can	   induce	   PS	   exposure	   on	   freshly	   isolated	   human	   RBCs,	   but	   whether	   this	   process	  
occurs	  in	  stored	  RBCs	  or	  changes	  during	  RBC	  aging	  is	  unknown.	  
STUDY	  DESIGN	   AND	  METHODS:	  RBCs	  were	  processed	  and	   stored	  according	   to	  Australian	  
blood	   banking	   guidelines.	   PS	   exposure	   was	   determined	   by	   Annexin	   V	   binding	   and	   flow	  
cytometry.	   Efficacy	   of	   P2X	   antagonists	   was	   assessed	   by	   flow	   cytometric	   measurements	   of	  
ATP-­‐induced	  ethidium+	  uptake	  in	  RPMI	  8226	  cells.	  Osmotic	  fragility	  was	  assessed	  by	  lysis	  in	  
hypotonic	  saline.	  RBCs	  were	  fractionated	  by	  discontinuous	  density	  centrifugation.	  
RESULTS:	   ATP	   (1	   mM)	   induced	   PS	   exposure	   on	   RBCs	   stored	   for	   less	   than	   1	   week.	   This	  
process	  was	  near-­‐completely	   inhibited	  by	  the	  P2X7	  antagonists,	  A438079	  and	  AZ10606120,	  
and	  the	  P2X1/P2X7	  antagonist,	  MRS2159,	  but	  not	  the	  P2X1	  antagonist,	  NF499.	  ATP-­‐induced	  
PS	  exposure	  on	  RBCs	  was	  not	  dependent	  on	  K+,	  Na+	  or	  Cl-­‐	  fluxes.	  ATP	  did	  not	  alter	  the	  osmotic	  
fragility	   of	   stored	   RBCs.	   ATP-­‐induced	   PS	   exposure	   was	   similar	   between	   RBCs	   of	   different	  
densities.	   ATP-­‐induced	   PS	   exposure	   was	   also	   similar	   between	   RBCs	   stored	   for	   less	   than	   1	  
week	  or	  for	  6	  weeks.	  
CONCLUSION:	  The	  propensity	  of	  RBCs	  to	  undergo	  P2X7-­‐mediated	  PS	  exposure	  does	  not	  alter	  
during	  in	  vivo	  and	  ex	  vivo	  aging.	  Thus,	  P2X7	  activation	  is	  unlikely	  to	  be	  involved	  in	  the	  removal	  
of	  senescent	  RBCs	  or	  stored	  RBCs	  following	  transfusion.	  
	  
Keywords:	  erythrocyte,	  blood	  storage,	  red	  cell	  storage	  lesion,	  purinergic	  receptor,	  purinergic	  
signaling.	  
	   	  
	   3	  
INTRODUCTION	  
During	  storage	  red	  blood	  cells	  (RBCs)	  undergo	  a	  series	  of	  biochemical	  and	  structural	  changes,	  
which	   are	   collectively	   termed	   the	   red	   cell	   storage	   lesion,	   and	   are	   associated	  with	   reduced	  
quality	  and	  lifespan	  of	  RBCs	  during	  storage	  and	  following	  transfusion.1	  These	  changes	  include	  
increased	   exposure	   of	   phosphatidylserine	   (PS)	   on	   the	   RBC	   plasma	   membrane,2	   which	  
parallels	   changes	   in	   RBCs	   aging	   in	   vivo.3	   Collectively,	   these	   and	   other	   studies	   support	   the	  
concept	   that	   RBCs	   continue	   to	   age	   during	   ex	   vivo	   storage.4	   PS	   exposure	   may	   facilitate	   the	  
removal	   of	   RBCs	   from	   the	   circulation	   by	   splenic	   and	   liver	   macrophages,	   potentially	  
contributing	  to	  the	  loss	  of	  stored	  RBCs	  following	  transfusion,	  as	  well	  as	  senescent	  RBCs	  and	  
RBCs	   in	  disease	  states	  such	  as	  sickle	  cell	  anemia	  and	   thalassemia.5	  Thus,	   there	   is	  continued	  
interest	  in	  identifying	  the	  mechanisms	  contributing	  to	  PS	  exposure	  on	  RBCs	  aged	  in	  vivo	  and	  
ex	  vivo.	  
Various	   stress	   treatments	   can	   induce	   PS	   exposure	   on	   freshly	   isolated	   and	   stored	  
RBCs.6,7	  Moreover,	  stored	  RBCs	  show	  an	  increased	  susceptibility	  to	  undergo	  stress-­‐induced	  PS	  
exposure,	  which	  may	  be	  responsible	  for	  the	  increased	  loss	  of	  RBCs	  following	  transfusion.6	  Our	  
group	  has	  shown	  that	  extracellular	  adenosine	  5’-­‐triphophate	  (ATP),	  via	  the	  activation	  of	  the	  
ATP-­‐gated	   cation	   channel	   P2X7,	   can	   also	   induce	   PS	   exposure	   on	   freshly	   isolated	   human	  
RBCs.8,9	  Whether	  P2X7	  activation	  can	  also	   induce	  PS	  exposure	  on	  stored	  RBCs	  and	  whether	  
such	   cells	   following	   extended	   storage	   display	   an	   increased	   propensity	   to	   undergo	   ATP-­‐
induced	   PS	   exposure	   is	   not	   known.	   Human	   RBCs	   also	   express	   P2X1,10,11	   which	   along	   with	  
P2X7	  belong	  to	  the	  P2X	  family	  of	  purinergic	  receptor	  channels.12	  However	  the	  contribution	  of	  
P2X1	  activation	  to	  ATP-­‐induced	  PS	  exposure	  remains	  unknown.	  Finally,	  in	  contrast	  to	  stress-­‐
induced	  PS	  exposure	  on	  RBCs,7	  P2X7-­‐induced	  PS	  exposure	  on	  these	  cells	  does	  not	  require	  Ca2+	  
influx	   and	   does	   not	   coincide	  with	   cell	   shrinkage,9	   however	   the	  mechanism	   by	  which	   P2X7	  
mediates	  PS	  on	  RBCs	  remains	  to	  be	  elucidated.	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Therefore,	  the	  aim	  of	  the	  study	  was	  to	  establish	  whether	  incubation	  with	  extracellular	  
ATP	  could	  induce	  PS	  exposure	  on	  stored	  RBCs,	  and	  if	  so	  whether	  this	  event	  was	  mediated	  by	  
P2X7	  or	  P2X1.	   Furthermore,	   this	   study	   aimed	   to	  determine	   if	  ATP-­‐induced	  PS	   exposure	   on	  
RBCs	  alters	  with	  in	  vivo	  or	  ex	  vivo	  aging.	  
	  
MATERIALS	  AND	  METHODS	  
Materials	  
ATP,	   MRS2159	   and	   adenine	   were	   from	   Sigma-­‐Aldrich	   (St.	   Louis,	   MO).	   A438079	   and	  
AZ10606120	   and	   (where	   indicated)	   NF499	   were	   from	   Tocris	   Bioscience	   (Ellisville,	   MO).	  
NF499	  was	   from	  Cayman	  Chemical	  (Ann	  Arbor,	  MI).	  Ethidium	  bromide	  was	   from	  AMRESCO	  
(Solon,	  OH).	  
	  
Preparation	  of	  red	  blood	  cells	  
The	  ethics	   committees	  of	   the	  University	  of	  Wollongong	  and	   the	  Australian	  Red	  Cross	  Blood	  
Service	  approved	  this	  project.	  Leukoreduced	  RBCs,	  from	  36	  randomly	  selected	  donors,	  were	  
collected	  and	  prepared	  as	  described,13	  and	  stored	  in	  saline	  adenine	  glucose	  mannitol	  (SAGM)	  
(Fresenius	   Kabi,	   Bad	   Homburg,	   Germany)	   at	   2-­‐6oC.	   All	   experiments	   were	   performed	   using	  
RBCs	  stored	  for	  less	  than	  1	  week	  (Week	  1	  RBCs)	  except	  when	  compared	  to	  RBCs	  stored	  for	  6	  
weeks	   (Week	   6	   RBCs).	   Prior	   to	   use,	   RBCs	   were	   rejuvenated	   using	   a	   minimally	   invasive	  
preconditioning	  protocol	  as	  recommended.14	  Briefly,	  1	  mL	  of	  RBCs	  in	  15	  mL	  preconditioning	  
medium	  (145	  mM	  NaCl,	  5	  mM	  KCl,	  10	  mM	  glucose,	  0.5	  mM	  CaCl2,	  0.1%	  bovine	  serum	  albumin	  
and	   10	  mM	  HEPES,	   pH	   7.4)	  were	   centrifuged	   (450	   x	  g	   for	   5	  minutes).	   RBCs	  were	   then	   re-­‐
suspended	  in	  15	  mL	  preconditioning	  medium	  and	  incubated	  at	  room	  temperature	  for	  1	  hour.	  
Finally,	  RBCs	  were	  centrifuged	  and	  washed	  twice	  with	  NaCl	  medium	  (147.5	  mM	  NaCl,	  2.5	  mM	  
KCl,	   5	   mM	   glucose,	   20	   mM	   HEPES,	   pH	   7.4).	   In	   some	   experiments,	   rejuvenated	   RBCs	   were	  
washed	  twice	  in	  KCl	  medium	  (150	  mM	  KCl,	  5	  mM	  glucose,	  20	  mM	  HEPES,	  pH	  7.4),	  N-­‐methyl-­‐
	   5	  
D-­‐glucamine	   (NMDG)	   Cl	  medium	   (147.5	  mM	  NMDG	   Cl,	   2.5	  mM	  KCl,	   5	  mM	   glucose,	   20	  mM	  
HEPES,	  pH	  7.4)	  or	  Na	  gluconate	  medium	  (147.5	  mM	  Na	  gluconate,	  2.5	  mM	  KCl,	  5	  mM	  glucose,	  
20	  mM	  HEPES,	  pH	  7.4)	  in	  place	  of	  NaCl	  medium.	  In	  other	  experiments,	  rejuvenated	  RBCs	  were	  
fractionated	   according	   to	   cell	   density	   using	   Percoll	   (GE	   Healthcare,	   Uppsala	   Sweden)	   as	  
previously	  described.6	  
	  
Maintenance	  and	  preparation	  of	  RPMI-­‐8226	  cells	  
Human	  multiple	  myeloma	  RPMI-­‐8226	  cells	  were	  maintained	  as	  described.15	  Prior	  to	  use,	  cells	  
were	   centrifuged	   (300	  x	  g	   for	  5	  minutes)	   and	  washed	   twice	  with	  dye	  uptake	  medium	  (145	  
mM	  NaCl,	  5	  mM	  KCl,	  5	  mM	  glucose,	  10	  mM	  HEPES,	  pH	  7.4).	  
	  
Annexin	  V	  binding	  
ATP-­‐induced	  PS	  exposure	  on	  RBCs	  was	  assessed	  as	  described.8	  Briefly,	  RBCs	  in	  NaCl	  medium	  
(unless	   otherwise	   indicated)	   in	   96-­‐well	   U-­‐bottom	   plates	  were	   incubated	   in	   the	   absence	   or	  
presence	  of	  1	  mM	  ATP	  for	  24	  hours	  at	  37oC.	  In	  some	  experiments,	  RBCs	  were	  pre-­‐incubated	  in	  
the	  absence	  or	  presence	  of	  P2X	  antagonist	  (as	  indicated)	  for	  15	  minutes	  at	  37oC	  prior	  to	  ATP	  
addition.	  Following	  ATP	  incubation,	  RBCs	  were	  gently	  re-­‐suspended	  within	  the	  original	  wells,	  
and	  20	  µL	  of	  RBCs	  were	  washed	  once	  in	  1	  mL	  Annexin	  V	  Binding	  Buffer	  (BioLegend,	  San	  Jose,	  
CA)	   (450	  X	   g	   for	   3	  minutes)	   and	   labeled	  with	   fluorescein	   isothiocyanate	   (FITC)-­‐conjugated	  
Annexin	  V	  (BioLegend)	  according	  to	  the	  manufacturer’s	  instructions.	  Data	  was	  collected	  using	  
a	   BD	   (San	   Jose,	   CA)	   LSR	   II	   flow	   cytometer	   and	   FACSDiva	   software,	   and	   the	   percentage	   of	  
Annexin	  V+	   cells	   (PS	   exposure)	  was	  determined	  using	   FlowJo	   software	   (Tree	   Star,	   Ashland,	  
OR).	   In	   some	   experiments,	   the	  mean	   fluorescence	   intensity	   (MFI)	   of	   Annexin	   V	   binding	   on	  
RBCs	  was	  determined	  using	  the	  geometric	  mean	  statistic	  of	  FlowJo	  software.	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Ethidium+	  uptake	  
ATP-­‐induced	  ethidium+	  uptake	  into	  RPMI	  8226	  cells	  was	  assessed	  as	  described.15	  Briefly,	  cells	  
in	  dye	  uptake	  medium	  were	  pre-­‐incubated	   in	   the	  absence	  or	  presence	  of	  P2X	  antagonist	  or	  
adenine	  (as	  indicated)	  for	  15	  minutes	  at	  37oC.	  Ethidium+	  was	  added	  (25	  µM),	  and	  cells	  were	  
incubated	   in	   the	  absence	  or	  presence	  of	  ATP	  (as	   indicated)	   for	  a	   further	  5	  minutes	  at	  37oC.	  
ATP	  incubations	  were	  stopped	  by	  addition	  of	  an	  equal	  volume	  of	  ice-­‐cold	  MgCl2	  medium	  (145	  
mM	  NaCl,	  5	  mM	  KCl,	  5	  mM	  glucose,	  20	  mM	  MgCl2,	  10	  mM	  HEPES,	  pH	  7.4)	  and	  centrifugation.	  
Data	   was	   collected	   using	   a	   LSR	   II	   flow	   cytometer	   and	   FACSDiva	   software,	   and	   the	   mean	  
fluorescence	  intensity	  of	  ethidium+	  uptake	  was	  determined	  using	  FlowJo	  software.	  
	  
Osmotic	  fragility	  
RBCs	   in	   NaCl	   medium	   (2%	   hematocrit)	   in	   96-­‐well	   U-­‐bottom	   plates	   (200	   µL/well)	   were	  
incubated	  in	  the	  absence	  or	  presence	  of	  1	  mM	  ATP	  for	  24	  hours	  at	  37oC.	  Osmotic	  fragility	  of	  
RBCs	  was	  then	  determined	  by	  lysis	  in	  buffered	  hypotonic	  saline	  as	  described.16	  Following	  ATP	  
incubation,	  RBCs	  were	  gently	  re-­‐suspended	  within	  the	  original	  wells,	  and	  90	  µL	  of	  RBCs	  from	  
each	   well	   incubated	   with	   180	   µL	   of	   buffered	   hypotonic	   saline	   solutions	   (to	   give	   final	  
concentrations	  of	  0.35-­‐0.6%	  (w/v)	  NaCl)	  or	  180	  µL	  of	  MilliQ	  water	  (100%	  lysis	  control)	  in	  96-­‐
well	  U-­‐bottom	  plates.	  RBCs	  were	  then	  incubated	  for	  30	  minutes	  at	  room	  temperature.	  Plates	  
were	  centrifuged	  (1000	  x	  g	  for	  5	  minutes)	  and	  supernatants	  measured	  at	  a	  wavelength	  of	  540	  
nm	  in	  a	  Molecular	  Devices	  (Sunnyvale,	  CA)	  Spectramax	  Plus	  384	  microplate	  reader.	  Percent	  
lysis	  was	  determined	  using	  the	  100%	  lysis	  control.	  
	  
Statistical	  analysis	  
Results	   are	   expressed	   as	   the	   mean	   ±	   standard	   error	   of	   the	   mean	   (SEM).	   Statistical	  
comparisons	  were	  performed	  using	  Prism	  5	  for	  Mac	  OS	  X	  (GraphPad	  Software,	  San	  Diego,	  CA).	  
Differences	  between	  two,	  or	  three	  or	  more	  groups	  were	  compared	  using	  a	  paired	  Student’s	  t-­‐
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test,	  or	  a	  one-­‐way	  analysis	  of	  variance	  (using	  Tukey’s	  multiple	  comparison	  test),	  respectively.	  
The	   relationship	   between	   ATP-­‐induced	   PS	   exposure	   and	   donor	   age	   at	   collection	   was	  




P2X7	  activation	  mediates	  PS	  exposure	  on	  stored	  RBCs	  
We	  have	  previously	  shown	  that	  extracellular	  ATP	  via	  P2X7	  activation	  induces	  PS	  exposure	  on	  
freshly	   isolated	  human	  RBCs.8,9	  Therefore,	   to	  determine	  if	   incubation	  with	  extracellular	  ATP	  
also	  induces	  PS	  exposure	  on	  RBCs	  stored	  for	  less	  than	  1	  week,	  RBCs	  from	  36	  different	  donors	  
were	   incubated	   in	   the	   absence	   or	   presence	   of	   ATP	   for	   24	   hours,	   and	   the	   percentage	   of	   PS	  
exposure	  on	  RBCs	  determined	  by	  Annexin	  V	  binding	   and	   flow	  cytometry.	   Incubation	   in	   the	  
absence	   of	   ATP	   resulted	   in	   a	   mean	   PS	   exposure	   of	   1.2	   ±	   0.1%	   (range	   0.4-­‐3.4%).	   ATP	  
incubation	   caused	   a	   five-­‐fold	   increase	   in	   the	   mean	   PS	   exposure	   to	   5.3	   ±	   0.5%	   (range	   0.4-­‐
13.6%;	  P	  <	  0.0001)	  (Fig.	  1A).	  Notably,	  ATP-­‐induced	  PS	  exposure	  was	  variable	  between	  donors	  
(mean	  of	  4.1	  ±	  0.5%,	  range	  0.0-­‐12.3%),	  with	  <1%	  ATP-­‐induced	  PS	  exposure	  on	  RBCs	  from	  five	  
donors	  and	  >10%	  ATP-­‐induced	  PS	  exposure	  on	  RBCs	  from	  two	  other	  donors	  (Fig.	  1B).	  ATP-­‐
induced	   PS	   exposure	   did	   not	   correlate	   with	   donor	   age,	   nor	   did	   ATP-­‐induced	   PS	   exposure	  
differ	  between	  female	  and	  male	  donors,	  or	  ABO	  or	  Rh	  blood	  groups	  (results	  not	  shown).	  
To	  determine	   if	  ATP-­‐induced	  PS	  exposure	  was	  mediated	  by	  P2X7,	   stored	  RBCs	  were	  
pre-­‐incubated	   with	   two	   known	   P2X7	   antagonists,	   A438079	   and	   AZ10606120,	   before	  
incubation	   with	   ATP	   for	   24	   hours.	   ATP	   incubation	   resulted	   in	   a	   four-­‐fold	   increase	   in	   PS	  
exposure	  compared	   to	  RBCs	   incubated	   in	   the	  absence	  of	  ATP	  (Fig.	  2A).	  Pre-­‐incubation	  with	  
either	   A438079	   or	   AZ10606120	   significantly	   impaired	   ATP-­‐induced	   PS	   exposure	   by	   an	  
average	   of	   96%	   (P	   <	   0.01)	   and	   99%	   (P	   <	   0.001),	   respectively	   (Fig.	   2A).	   PS	   exposure	   was	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similar	   on	   RBCs	   incubated	   in	   the	   absence	   of	   both	   ATP	   and	   antagonist	   compared	   to	   RBCs	  
incubated	  with	  antagonist	  alone	  (Fig.	  2A).	  
To	   determine	   if	   P2X1,	   which	   is	   also	   present	   on	   human	   RBCs,10,11	  may	   contribute	   to	  
ATP-­‐induced	  PS	  exposure	  on	  RBCs,	   stored	  RBCs	  were	  pre-­‐incubated	  with	   two	  known	  P2X1	  
antagonists,	  MRS2159	   and	  NF499,	   before	   incubation	  with	   ATP	   for	   24	   hours.	   A438079	  was	  
included	   as	   a	   positive	   control.	   Again,	   ATP	   incubation	   resulted	   in	   a	   five-­‐fold	   increase	   in	   PS	  
exposure	  and	  pre-­‐incubation	  with	  A438079	  significantly	  impaired	  this	  process	  by	  an	  average	  
of	   98%	   (P	   <	   0.05;	   Fig.	   2B).	   Pre-­‐incubation	  with	  MRS2159	   also	   significantly	   impaired	   ATP-­‐
induced	  PS	  exposure	  by	  an	  average	  of	  94%	  (P	  <	  0.05;	  Fig.	  2B).	  In	  contrast,	  pre-­‐incubation	  with	  
NF499	   failed	   to	   impair	   ATP-­‐induced	   PS	   exposure	   (P	   >	   0.05;	   Fig.	   2B).	   Similar	   results	   were	  
observed	  with	  NF499	  obtained	   from	  a	  second	  manufacturer	   (Tocris	  Bioscience)	  using	  RBCs	  
from	  four	  different	  donors	  (results	  not	  shown).	  PS	  exposure	  was	  similar	  on	  RBCs	  incubated	  in	  
the	  absence	  of	  ATP	  and	  antagonist	  compared	  to	  RBCs	  incubated	  with	  either	  antagonist	  alone	  
(Fig.	  2B).	  
To	  explore	  the	  possibility	  that	  MRS2159	  but	  not	  NF499	  impairs	  P2X7,	  RPMI	  8226	  cells,	  
which	   express	   high	   amounts	   of	   functional	   P2X7	   but	   negligible	   P2X1,15	   were	   pre-­‐incubated	  
with	  increasing	  concentrations	  of	  either	  MRS2159	  or	  NF499,	  and	  the	  ATP-­‐induced	  uptake	  of	  
ethidium+	  assessed	  by	  flow	  cytometry.	  A438079	  was	  included	  as	  a	  positive	  control.	  Similar	  to	  
previous	   findings,17	   A438079	   impaired	   ATP-­‐induced	   ethidium+	   uptake	   in	   a	   concentration-­‐
dependent	  manner	  with	  a	  half	  maximal	   inhibitory	  concentration	  (IC50)	  of	  668	  ±	  40	  nM	  (Fig.	  
2C).	   MRS2159	   also	   impaired	   ATP-­‐induced	   ethidium+	   uptake	   concentration-­‐dependent	  
manner,	  but	  with	  an	  IC50	  of	  40	  ±	  5	  nM	  (Fig.	  2C).	  In	  contrast,	  NF499,	  up	  to	  a	  concentration	  of	  10	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P2X7-­‐mediated	  PS	  exposure	  on	  stored	  RBCs	  is	  not	  dependent	  on	  K+,	  Na+	  or	  Cl-­‐	  fluxes	  
P2X7-­‐mediated	  PS	  exposure	  on	  RBCs	  does	  not	   require	  Ca2+	   influx,9	  however	  K+,	  Na+	  and	  Cl-­‐	  
fluxes	  can	  participate	   in	  stress-­‐induced	  PS	  exposure	  on	  RBCs.18-­‐20	  Therefore,	   to	  examine	  the	  
role	  of	   these	   ion	   fluxes	   in	  P2X7-­‐mediated	  PS	  exposure	  on	  RBCs,	   cells	  were	   re-­‐suspended	   in	  
either	  NaCl,	   KCl,	   NMDG	  Cl	   or	  Na	   gluconate	  medium	   and	   the	  ATP-­‐induced	   PS	   exposure	  was	  
assessed	  as	  above.	  KCl	  medium	  prevents	  the	  net	   loss	  of	   intracellular	  K+,	  while	  NMDG	  Cl	  and	  
Na	  gluconate	  media	  are	  nominally	  free	  of	  Na+	  and	  Cl-­‐	  ions,	  respectively,	  and	  thus	  prevent	  the	  
respective	  net	  influx	  of	  Na+	  or	  Cl-­‐	  ions.	  As	  above,	  ATP	  induced	  a	  five-­‐	  to	  six-­‐fold	  increase	  in	  PS	  
exposure	  on	  RBCs	  suspended	  in	  NaCl	  medium	  compared	  to	  RBCs	  in	  NaCl	  medium	  incubated	  
in	  the	  absence	  of	  ATP	  (Fig.	  3A,B).	  ATP	  induced	  a	  eight-­‐fold,	  five-­‐fold	  and	  seven-­‐fold	  increase	  
in	  PS	  exposure	  on	  RBCs	  suspended	  in	  KCl	  (P	  <	  0.01),	  NMDG	  Cl	  (P	  <	  0.05)	  or	  Na	  gluconate	  (P	  <	  
0.001)	  medium,	   respectively,	   compared	   to	  RBCs	   in	   corresponding	  medium	   incubated	   in	   the	  
absence	  of	  ATP	  (Fig.	  3A,B).	  PS	  exposure	  on	  RBCs	  incubated	  in	  the	  absence	  of	  ATP	  was	  similar	  
between	  the	  four	  different	  media	  (Fig.	  3A,B).	  
	  
Adenine	  does	  not	  impair	  P2X7	  activation	  
Due	   to	   structural	   similarities,	   ATP	   derivatives	   may	   potentially	   impair	   P2X7	   activation	   by	  
binding	   to	   the	   ATP-­‐binding	   site.	   Notably,	   SAGM	   and	   SAGM2	   additive	   solutions	   contain	  
approximately	  485	  and	  910	  µM	  adenine,	  respectively.	  Thus,	  there	  is	  a	  possibility	  that	  adenine	  
may	   prevent	   P2X7	   activation	   on	   RBCs	   during	   storage.	   To	   determine	   if	   adenine	   can	   impair	  
P2X7	   activation,	   RPMI	   8226	   cells	   were	   pre-­‐incubated	  with	   either	   485	   or	   910	   µM	   adenine,	  
followed	   by	   incubation	   with	   increasing	   ATP	   concentrations	   and	   ethidium+	   uptake	   was	  
assessed	  as	  above.	  As	  repeatedly	  observed	  with	  this	  cell	   line,15,21	   incubation	  with	  ATP	  alone	  
induced	  ethidium+	  uptake	  in	  a	  concentration-­‐dependent	  manner	  with	  a	  half	  maximal	  effective	  
concentration	   (EC50)	   of	   104	   ±	   7	   µM	   and	   near-­‐maximal	   uptake	   at	   0.3	   mM	   (Fig.	   4).	   Similar	  
results	  were	  observed	  following	  pre-­‐incubation	  with	  either	  485	  or	  910	  µM	  adenine,	  with	  an	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EC50	  of	  99	  ±	  11	  µM	  and	  103	  ±	  9	  µM,	  respectively	  and	  near-­‐maximal	  ethidium+	  uptake	  at	  0.3	  
mM	  ATP	  at	  either	  adenine	  concentration	  (Fig.	  4).	  Basal	  ethidium+	  uptake	   in	   the	  presence	  of	  
adenine	  was	  similar	  to	  basal	  ethidium+	  uptake	  in	  the	  absence	  of	  adenine	  (results	  not	  shown).	  
Additionally,	  RPMI	  8226	  cells	  were	  pre-­‐incubated	  with	  increasing	  concentrations	  of	  adenine,	  
followed	  by	   incubation	  with	  120	  µM	  ATP	  and	   the	  ethidium+	  uptake	  assessed	  as	  above.	  Pre-­‐
incubation	  of	  RPMI	  8226	  cells	  with	  adenine	  up	  to	  concentrations	  of	  3	  mM	  did	  not	  alter	  ATP-­‐
induced	  ethidium+	  uptake	  (results	  not	  shown).	  
	  
Extracellular	  ATP	  does	  not	  alter	  osmotic	  fragility	  of	  stored	  RBCs	  
Extracellular	  ATP,	  especially	  via	  P2X7	  activation,	  induces	  various	  membrane-­‐related	  changes	  
in	   a	   number	   of	   cell	   types.22	   Therefore,	   to	   examine	   if	   ATP	   incubation	   altered	   the	   osmotic	  
fragility	   (membrane	   resistance)	   of	   stored	   RBCs,	   cells	   were	   incubated	   in	   the	   absence	   or	  
presence	   of	   ATP,	   and	   then	   the	   osmotic	   fragility	   of	   these	   cells	   was	   assessed	   by	   lysis	   in	  
hypotonic	   saline	   solutions	   and	   spectrophotometry.	   As	   expected,	   increasing	   hypotonicity	  
induced	   the	   lysis	   of	   RBCs	   following	   incubation	   in	   the	   absence	   of	   ATP	   in	   a	   concentration-­‐
dependent	  manner	  and	  with	  50%	  of	  lysis	  occurring	  at	  a	  saline	  concentration	  of	  0.39	  ±	  0.01%	  
(Fig.	   5).	   Near	   identical	   results	   were	   observed	   with	   RBCs	   following	   ATP	   incubation,	   with	  
increasing	  hypotonicity	  inducing	  lysis	  in	  a	  concentration-­‐dependent	  manner	  and	  with	  50%	  of	  
lysis	  also	  occurring	  at	  a	  saline	  concentration	  of	  0.39	  ±	  0.01%	  (Fig.	  5).	  
	  
P2X7	  activation	  mediates	  PS	  exposure	  on	  RBCs	  aged	  in	  vivo	  or	  ex	  vivo	  
To	   determine	   if	   the	   amount	   of	   P2X7-­‐mediated	   PS	   exposure	   changes	   during	   the	   lifespan	   of	  
RBCs	   in	   vivo,	   RBCs	  were	   separated	   into	   four	   fractions,	   using	   discontinuous	   Percoll	   density	  
centrifugation,	  enriched	  with	  RBCs	  of	  various	  ages.	  Fractions	  1	  and	  4	  represent	  younger	  and	  
older	   RBCs,	   respectively,	   while	   Fractions	   2	   and	   3	   represent	   RBCs	   of	   intermediate	   ages.23	  
Unfractionated	  and	  fractionated	  RBCs	  were	  then	  incubated	  in	  the	  absence	  or	  presence	  of	  ATP,	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and	  PS	  exposure	  was	  assessed	  as	  above.	  ATP	  induced	  a	  four-­‐fold	  increase	  in	  PS	  exposure	  on	  
unfractionated	  RBCs	  compared	  to	  unfractionated	  RBCs	  incubated	  in	  the	  absence	  of	  ATP	  (P	  <	  
0.001;	  Fig.	  6).	  Increases	  in	  ATP-­‐induced	  PS	  exposure	  of	  a	  similar	  magnitude	  were	  observed	  on	  
RBCs	   in	   each	   of	   the	   four	   fractions	   (P	   <	   0.001;	   Fig.	   6).	   PS	   exposure	   was	   similar	   between	  
unfractionated	   RBCs	   and	   RBCs	   in	   each	   fraction	   incubated	   in	   the	   absence	   of	   ATP	   (Fig.	   6).	  
Similar	   results	   between	   unfractionated	   and	   fractionated	   RBCs	   were	   observed	   when	   ATP-­‐
induced	  PS	  exposure	  was	  examined	  as	  MFI	  of	  Annexin	  V	  binding	  (results	  not	  shown).	  
Finally,	   to	   determine	   if	   the	   amount	   of	   P2X7-­‐mediated	  PS	   exposure	   changes	   on	  RBCs	  
aged	   ex	   vivo,	   ATP-­‐induced	   PS	   exposure	  was	   assessed	   on	   RBCs	   stored	   for	   less	   than	   1	  week	  
(Week	  1	  RBCs)	  and	  for	  6	  weeks	  (Week	  6	  RBCs).	  ATP	  induced	  a	  mean	  four-­‐fold	  increase	  in	  PS	  
exposure	  on	  Week	  1	  RBCs	  compared	  to	  Week	  1	  RBCs	   incubated	   in	   the	  absence	  of	  ATP	  (P	  <	  
0.001;	  Fig.	  7A).	  Similarly,	  ATP	   induced	  a	  mean	  four-­‐fold	   increase	   in	  PS	  exposure	  on	  Week	  6	  
RBCs	  compared	  to	  Week	  6	  RBCs	  incubated	  in	  the	  absence	  of	  ATP	  (P	  <	  0.001;	  Fig.	  7A).	  Further,	  
mean	  ATP-­‐induced	  PS	   exposure	  was	   similar	   between	  Week	  1	  RBCs	   and	  Week	  6	  RBCs	   (P	   =	  
0.7034;	  Fig.	  7B).	  ATP-­‐induced	  PS	  exposure	  on	  RBCs	  from	  most	  donors	  decreased	  or	  increased	  
slightly	   over	   the	   6-­‐weeks	   storage	   period,	   however	   these	   changes	   did	   not	   exceed	   a	   50%	  
reduction	  or	   two-­‐fold	   increase,	   respectively,	  with	   the	   exception	  of	  RBCs	   from	  one	  donor	   in	  
which	  a	  2-­‐fold	  increase	  was	  observed	  (Fig.	  7B).	  Similar	  results	  between	  Week	  1	  and	  Week	  6	  
RBCs	   were	   observed	   when	   ATP-­‐induced	   PS	   exposure	   was	   examined	   as	   MFI	   of	   Annexin	   V	  
binding	  (results	  not	  shown).	  
	  
DISCUSSION	  
P2X1	  and	  P2X7	  are	  the	  only	  reported	  functional	  P2X	  receptors	  on	  human	  RBCs.10,24,25	  Further,	  
P2X7	   activation	   is	   known	   to	   induce	   PS	   exposure	   on	   freshly	   isolated	   human	   RBCs.8,9	   Using	  
stored	   human	   RBC	   concentrates	   the	   current	   study	   demonstrates	   that	   ATP	   induces	   PS	  
exposure	   on	   stored	   RBCs	   and	   that	   this	   process	   is	   mediated	   by	   P2X7	   but	   not	   P2X1.	   ATP-­‐
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induced	   PS	   exposure	   on	   stored	   RBCs	   was	   near-­‐completely	   inhibited	   by	   two	   structurally	  
unrelated	  P2X7	  antagonists,	  A438079	  and	  AZ10606120,26,27	  but	  not	  by	  the	  P2X1	  antagonist,	  
NF499.28	   ATP-­‐induced	   PS	   exposure	   on	   RBCs	   was	   also	   impaired	   by	   MRS2159,	   which	   is	  
generally	  considered	  a	  P2X1	  antagonist.29	  However,	  measurements	  of	  ATP-­‐induced	  ethidium+	  
uptake	  into	  human	  RPMI	  8226	  cells	  demonstrated	  that	  MRS2159	  is	  also	  a	  potent	  antagonist	  of	  
P2X7	  with	   an	   IC50	   at	   least	   one	   log	   lower	   than	   that	   of	  A438079.	  Notably,	  MRS2159,	   but	   not	  
NF449,	  has	  also	  been	  shown	  to	   impair	  ATP-­‐induced	  Ca2+	   fluxes	   in	  HEK-­‐293	  cells	  expressing	  
heterologous	   P2X7.30	   Collectively,	   these	   two	   findings	   support	   the	   concept	   that	  MRS2159	   is	  
also	  an	  antagonist	  of	  P2X7	  and	  that	  ATP-­‐induced	  PS	  exposure	  on	  stored	  RBCs	  is	  mediated	  by	  
P2X7	  and	  not	  P2X1.	  The	   absence	  of	   a	   role	   for	  P2X1	   in	  ATP-­‐induced	  PS	   exposure	  on	   stored	  
RBCs,	  is	  consistent	  with	  our	  previous	  findings	  in	  which	  adenosine	  5’-­‐diphosphate,	  an	  agonist	  
of	  P2X1	  but	  not	  P2X7,31	   failed	   to	   induce	  PS	   exposure	  on	   freshly	   isolated	  RBCs.9	  Thus,	  ATP-­‐
induced	  PS	  exposure	  in	  human	  RBCs	  appears	  to	  be	  exclusively	  mediated	  by	  P2X7.	  In	  contrast,	  
both	   P2X1	   and	   P2X7	  may	   be	   involved	   in	   other	   signaling	   events	   in	   human	  RBCs	   such	   as	  α-­‐
hemolysin-­‐,	  leukotoxin-­‐	  and	  complement-­‐induced	  hemolysis	  of	  human	  RBCs.10,32-­‐34	  
ATP-­‐induced	  PS	  exposure	  was	  similar	  between	  fractions	  enriched	  with	  RBCs	  of	  various	  
ages.	  These	  four	  fractions	  contained	  RBCs	  of	  increasing	  density,	  a	  useful	  but	  imprecise	  marker	  
of	   cell	   age.23	   Thus,	   the	   current	   study	   demonstrates	   that	   the	   amount	   of	   P2X7-­‐mediated	   PS	  
exposure	   on	   human	   RBCs	   does	   not	   significantly	   change	   during	   in	   vivo	   aging.	   These	   results	  
contrast	  findings	  with	  hyperosmotic	  stress-­‐induced	  PS	  exposure	  on	  fractionated	  RBCs.6	  In	  this	  
prior	  study,	  RBCs	  fractions,	  isolated	  in	  the	  same	  manner	  as	  the	  current	  study,	  demonstrated	  
that	   increased	  cell	  density	  was	  associated	  with	   increased	  susceptibility	  to	  stress-­‐induced	  PS	  
exposure.	   Similarly,	   this	   same	   group,	   using	   elutriation	   followed	   by	   discontinuous	   density	  
gradient	  centrifugation,	  demonstrated	  that	   increased	  cell	  age	  was	  associated	  with	   increased	  
susceptibility	   to	   PS	   exposure	   induced	   by	   energy	   (glucose)	   depletion.35	   On	   average,	   ATP-­‐
induced	  PS	   exposure	  was	   also	   similar	   between	  RBCs	   stored	   for	   less	   than	  1	  week	   and	   for	  6	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weeks.	  During	   storage,	  RBCs	  undergo	   a	  number	  of	   biochemical	   and	   structural	   changes	   that	  
parallel	  that	  of	  aging	  RBCs	  in	  vivo	  and	  as	  such	  RBCs	  are	  also	  considered	  to	  age	  ex	  vivo.4	  Thus,	  
the	   current	   study	   demonstrates	   that	   the	   amount	   of	   P2X7-­‐mediated	   PS	   exposure	   on	   human	  
RBCs	  does	  not	  significantly	  change	  during	  ex	  vivo	  aging.	  Again	  these	  results	  contrast	  findings	  
with	  hyperosmotic	  stress-­‐induced	  PS	  exposure	  on	  stored	  RBCs.6	  In	  this	  previous	  study,	  RBCs	  
demonstrated	   that	   increased	   storage	   time	   was	   associated	   with	   increased	   susceptibility	   to	  
stress-­‐induced	  PS	  exposure.	  	  
The	   reasons	   for	   the	   differences	   between	   stress-­‐induced	   and	   P2X7-­‐mediated	   PS	  
exposure	   in	   aged	   RBCs	   in	   the	   previously	  mentioned	   studies	   and	   the	   current	   study	   remain	  
unknown,	  but	  may	  relate	  to	  differences	  in	  the	  signaling	  pathways	  involved.	  P2X7-­‐mediated	  PS	  
exposure	  on	  RBCs	   is	   independent	  of	  Ca2+	   influx,9	  while	  stress-­‐induced	  PS	  exposure	  requires	  
Ca2+	  influx.7	  Moreover,	  stress-­‐induced	  PS	  exposure	  on	  RBCs	  is	  partly	  dependent	  on	  K+	  and	  Cl-­‐	  
fluxes,	  while	  Na+	  influx	  may	  also	  play	  a	  role	  in	  this	  process	  in	  these	  cells.18-­‐20	  In	  contrast,	  using	  
medium	  either	  nominally	  free	  of	  Na+	  or	  Cl-­‐,	  or	  medium	  containing	  a	  high	  concentration	  of	  K+,	  
the	  current	  study	  was	  unable	  to	  demonstrate	  a	  role	  for	  Na+	  or	  Cl-­‐	  influx	  or	  K+	  efflux	  in	  P2X7-­‐
mediated	   PS	   exposure	   on	   RBCs.	   The	   increase	   in	   ATP-­‐induced	   PS	   exposure	   seen	   in	   RBCs	  
incubated	  in	  either	  KCl	  or	  NMDG	  Cl	  medium	  compared	  to	  NaCl	  medium,	  is	  consistent	  with	  the	  
well-­‐known	  inhibitory	  role	  of	  Na+	  on	  P2X7	  activation.36	  
Using	  RBC	  concentrates	  from	  36	  different	  donors	  the	  current	  study	  demonstrates	  that	  
the	   amount	   of	   P2X7-­‐mediated	   PS	   exposure	   varies	   between	   individuals.	   This	   variability	   is	  
consistent	  with	  observed	  variation	  in	  other	  P2X7-­‐mediated	  events	  including	  ethidium+	  uptake	  
into	  leukocytes,	  which	  is	  predominately	  explained	  by	  single	  nucleotide	  polymorphisms	  in	  the	  
P2RX7	  gene	  that	  alter	  receptor	  function.37,38	  Thus,	  the	  variability	  observed	  in	  P2X7-­‐mediated	  
PS	  exposure	  on	  stored	  RBCs	  between	  donors	   is	  most	   likely	  due	  to	   loss-­‐	  or	  gain-­‐of-­‐functions	  
polymorphisms	  in	  the	  P2RX7	  gene.	  In	  support	  of	  this,	  we	  have	  previously	  shown	  that	  loss-­‐	  or	  
gain-­‐of-­‐functions	   polymorphisms	   alter	   RBC	   P2X7	   function	   accordingly,24,39	   including	   ATP-­‐
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induced	  PS	  exposure	  in	  freshly	  isolated	  human	  RBCs.9	  Due	  to	  logistical	  and	  ethical	  constraints	  
in	   this	   study	   it	  was	  not	  possible	   to	   collect	  DNA	   from	   the	  volunteer	  blood	  donors.	  Thus,	   the	  
P2RX7	  genotype	  of	  all	  donors	  in	  the	  current	  study	  remains	  unknown.	  Of	  note,	  PS	  exposure	  on	  
stored	   RBCs	  may	   serve	   as	   parameter	   for	   donor-­‐dependent	   variation	   in	   the	   quality	   of	   RBC	  
concentrates.40	   Therefore,	   it	   remains	   possible	   that	   P2RX7	   genotype	   and	   the	   propensity	   of	  
RBCs	   to	   undergo	   P2X7-­‐mediated	   PS	   exposure	   may	   contribute	   to	   this	   donor-­‐dependent	  
variation	  in	  RBC	  product	  quality.	  
The	  physiological	   role	  of	  P2X7-­‐mediated	  PS	  exposure	  on	  human	  RBCs	   remains	   to	  be	  
elucidated.	  Given	  that	  this	  process	  does	  not	   increase	  during	  RBC	  aging	  (this	  study)	  and	  that	  
direct	   evidence	   for	   PS	   exposure	   in	   the	   removal	   of	   senescent	   RBCs	   is	   lacking,1	   it	   appears	  
unlikely	   that	   P2X7-­‐mediated	   PS	   exposure	   plays	   a	   major	   role	   in	   the	   removal	   of	   healthy,	  
senescent	   RBCs.	   Rather	   it	   remains	   possible	   that	   ATP-­‐induced	   PS	   exposure	   may	   act	   as	   a	  
marker	  of	  recent	  P2X7	  activation	  and	  that	  some	  other	  P2X7-­‐mediated	  event,	  such	  as	  the	  ATP-­‐
induced	   release	   of	   epoxyeicosatrienoic	   acids	   (as	   observed	   with	   rat	   RBCs),41	   is	   the	   main	  
physiological	   role	   of	   P2X7	   activation	   in	   human	   RBCs.	   Alternatively,	   given	   that	   P2X7	  
transcripts	   are	   found	   in	   human	   RBC	   progenitors42	   and	   that	   relatively	   high	   amounts	   of	  
functional	  P2X7	  are	  found	  in	  a	  murine	  RBC	  progenitor	  cell	  line,43,44	  this	  receptor	  may	  serve	  an	  
important	   role	   in	   erythropoiesis.	   If	   so,	   P2X7	   on	   mature	   RBCs	   may	   be	   an	   evolutionary	   or	  
functional	   relic,	   as	   proposed	   for	   other	   RBC	   membrane	   proteins.45,46	   However	   it	   has	   been	  
recently	   argued	   that	   so-­‐called	   relic	   channels,	   specifically	   the	   Gardos	   channel	   and	   voltage-­‐
dependent	  anion	  channel,	  may	  serve	  important	  roles	  in	  RBC	  homeostasis.46	  Thus,	  a	  potential	  
role	   for	   P2X7	   in	   RBC	   homeostasis	   cannot	   be	   excluded	   at	   this	   time.	   Finally,	   it	   needs	   to	   be	  
considered	  that	  P2X7	  on	  RBCs	  may	  be	  important	  in	  certain	  pathophysiological	  states,	  even	  in	  
the	  absence	  of	  a	  role	  for	  this	  receptor	  in	  healthy	  RBCs.	  P2X7	  along	  with	  P2X1	  are	  thought	  to	  
be	   important	   in	   facilitating	   bacterial	   toxin-­‐	   and	   complement-­‐induced	   hemolysis	   of	   human	  
RBCs.10,32-­‐34	  Additionally,	  P2X7	  activation	  is	  deemed	  to	  allow	  malarial	  parasites	  to	   invade	  or	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escape	   RBCs.47,48	   Thus,	   given	   the	   presence	   of	   functional	   P2X7	   on	   stored	   RBCs,	   RBC	  
concentrates	  may	  provide	  a	  readily	  available	  source	  to	  further	  elucidate	  the	  physiological	  and	  
pathophysiological	  roles	  of	  P2X7	  in	  human	  RBCs.	  
In	   conclusion,	   the	   current	   study	   indicates	   that	   the	   propensity	   of	   RBCs	   to	   undergo	  
P2X7-­‐mediated	  PS	  exposure	  does	  not	  alter	  during	  in	  vivo	  and	  ex	  vivo	  aging.	  This	  suggests	  that	  
P2X7	  activation	  is	  unlikely	  to	  be	  a	  common	  mechanism	  in	  the	  removal	  of	  senescent	  RBCs	  or	  
stored	  RBCs	  following	  transfusion.	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FIGURE	  LEGENDS	  
	  
Fig.	  1.	  ATP	   induces	  PS	  exposure	  on	  stored	  RBCs.	   (A,	  B)	  Week	  1	  RBCs	   in	  NaCl	  medium	  were	  
incubated	   in	  the	  absence	  or	  presence	  of	  1	  mM	  ATP	  for	  24	  hours	  at	  37oC.	  Cells	  were	   labeled	  
with	  FITC-­‐conjugated	  Annexin	  V	  and	  analyzed	  by	  flow	  cytometry.	  (A)	  Each	  symbol	  represents	  
the	   percentage	   of	   Annexin	  V+	   RBCs,	   from	  36	   individual	   donors,	   following	   incubation	   in	   the	  
absence	   (basal)	   or	   presence	   of	   ATP;	   ****P	   <	   0.0001	   compared	   to	   basal.	   (B)	   Each	   symbol	  
represents	  the	  percentage	  of	  ATP-­‐induced	  PS	  exposure	  RBCs,	  from	  the	  36	  individual	  donors,	  
determined	  as	  the	  difference	  in	  the	  percentage	  of	  Annexin	  V+	  RBCs	  following	  incubation	  in	  the	  
presence	  and	  absence	  of	  ATP;	  bar	  represents	  group	  mean.	  
	  
Fig.	  2.	  P2X7	  antagonists	  impair	  ATP-­‐induced	  PS	  exposure	  on	  stored	  RBCs.	  (A,	  B)	  Week	  1	  RBCs	  
in	  NaCl	  medium	  were	  pre-­‐incubated	  for	  15	  minutes	  in	  the	  absence	  or	  presence	  of	  (A,	  B)	  10	  µM	  
A438079,	  (A)	  1	  µM	  AZ10606120	  or	  (B)	  10	  µM	  MRS2159	  or	  10	  µM	  NF499,	  and	  (A,	  B)	  then	  in	  
the	  absence	  (basal)	  or	  presence	  of	  1	  mM	  ATP	   for	  24	  hours	  at	  37oC.	  Cells	  were	   labeled	  with	  
FITC-­‐conjugated	   Annexin	   V	   and	   analyzed	   by	   flow	   cytometry.	   (C)	   RPMI	   8226	   cells	   in	   dye	  
uptake	  medium	  were	  pre-­‐incubated	   for	  15	  minutes	   in	   the	  absence	  or	  presence	  of	  A438079,	  
MRS2159	  or	  NF499	  (as	  indicated).	  Ethidium+	  (25	  µM)	  was	  then	  added	  and	  the	  cells	  incubated	  
in	  the	  absence	  or	  presence	  of	  120	  µM	  ATP	  (approximate	  to	  the	  EC50	  for	  human	  P2X7)15	  for	  5	  
minutes	  at	  37oC.	  Incubations	  were	  stopped	  by	  addition	  of	  MgCl2	  medium	  and	  centrifugation,	  
and	  the	  mean	  fluorescence	  intensity	  of	  ethidium+	  uptake	  determined	  by	  flow	  cytometry.	  (A,	  B)	  
Results	  are	  mean	  ±	  SEM	  (A,	  n	  =	  3	  individual	  donors;	  B,	  n	  =	  4	  individual	  donors);	  *P	  <	  0.05	  or	  
***P	  <	  0.001	  compared	  to	  corresponding	  basal,	  †P	  <	  0.05,	  ††P	  <	  0.01	  or	  †††P	  <	  0.001	  compared	  
to	   corresponding	   ATP	   alone.	   (C)	   Results	   are	   percent	   maximum	   response	   to	   ATP	   in	   the	  
absence	  of	  antagonist	  (mean	  ±	  SEM,	  n	  =	  3	  experiments).	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Fig.	  3.	  P2X7-­‐mediated	  PS	  exposure	  on	  stored	  RBCs	  is	  not	  dependent	  on	  K+,	  Na+	  or	  Cl-­‐	   fluxes.	  
Week	  1	  RBCs	  in	  (A,	  B)	  NaCl,	  (A),	  KCl,	  NMDG	  Cl	  or	  (B)	  Na	  gluconate	  medium	  were	  incubated	  in	  
the	  absence	  (basal)	  or	  presence	  of	  1	  mM	  ATP	   for	  24	  hours	  at	  37oC.	  Cells	  were	   labeled	  with	  
FITC-­‐conjugated	  Annexin	  V	  and	  analyzed	  by	  flow	  cytometry.	  Results	  are	  mean	  ±	  SEM	  (A,	  n	  =	  5	  
individual	  donors;	  B,	  n	  =	  4	   individual	  donors	  studied	   in	   triplicate);	  *P	  <	  0.05,	  **P	  <	  0.01	  or	  
***P	  <	  0.001	  compared	  to	  corresponding	  basal.	  
	  
Fig.	  4.	  Adenine	  does	  not	  impair	  P2X7	  activation.	  RPMI	  8226	  cells	  in	  dye	  uptake	  medium	  were	  
pre-­‐incubated	   for	   15	   minutes	   in	   the	   absence	   (control)	   or	   presence	   of	   485	   µM	   or	   910	   µM	  
adenine.	   Ethidium+	   (25	   µM)	   was	   then	   added	   and	   the	   cells	   incubated	   in	   the	   absence	   or	  
presence	  of	  ATP	  (as	  indicated)	  for	  5	  minutes	  at	  37oC.	  Incubations	  were	  stopped	  by	  addition	  of	  
MgCl2	  medium	  and	  centrifugation,	  and	   the	  mean	   fluorescence	   intensity	  of	  ethidium+	  uptake	  
determined	  by	   flow	  cytometry.	  Results	   are	  percent	  maximum	  response	   to	  1	  mM	  ATP	  alone	  
(mean	  ±	  SEM,	  n	  =	  3	  experiments).	  
	  
Fig.	  5.	  Extracellular	  ATP	  does	  not	  alter	  osmotic	  fragility	  of	  stored	  RBCs.	  Week	  1	  RBCs	  in	  NaCl	  
medium	  were	  incubated	  in	  the	  absence	  or	  presence	  of	  1	  mM	  ATP	  for	  24	  hours	  at	  37oC.	  Cells	  
were	   then	   incubated	   in	   buffered	   hypotonic	   saline	   (as	   indicated)	   for	   30	   minutes	   at	   room	  
temperature,	   and	   the	   absorbance	   of	   supernatants	  measured	   by	   spectrophotometry.	   Results	  
are	  percent	  lysis	  compared	  100%	  lysis	  control	  (n	  =	  3	  individual	  donors).	  
	  
Fig.	   6.	   P2X7	   activation	   mediates	   PS	   exposure	   on	   RBCs	   aged	   in	   vivo.	   Week	   1	   RBCs	   were	  
separated	   by	   discontinuous	   Percoll	   density	   centrifugation	   into	   four	   fractions	   of	   increasing	  
density	   (Fractions	  1-­‐4,	   respectively).	  Unfractionated	  and	   fractionated	  RBCs	   in	  NaCl	  medium	  
were	  then	  incubated	  in	  the	  absence	  or	  presence	  of	  1	  mM	  ATP	  for	  24	  hours	  at	  37oC.	  Cells	  were	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labeled	  with	  FITC-­‐conjugated	  Annexin	  V	  and	  analyzed	  by	  flow	  cytometry.	  Results	  are	  mean	  ±	  
SEM	  (n	  =	  3	  individual	  donors);	  ***P	  <	  0.001	  compared	  to	  corresponding	  basal.	  
	  
Fig.	  7.	  P2X7	  activation	  mediates	  PS	  exposure	  on	  RBCs	  aged	  ex	  vivo.	  (A,	  B)	  Week	  1	  and	  Week	  6	  
RBCs	  in	  NaCl	  medium	  were	  incubated	  in	  the	  absence	  or	  presence	  of	  1	  mM	  ATP	  for	  24	  hours	  at	  
37oC.	  Cells	  were	  labeled	  with	  FITC-­‐conjugated	  Annexin	  V	  and	  analyzed	  by	  flow	  cytometry.	  (A)	  
Results	  are	  mean	  ±	  SEM	  (n	  =	  15	  individual	  donors);	  ***P	  <	  0.001	  compared	  to	  corresponding	  
basal.	  (B)	  Each	  symbol	  represents	  the	  percentage	  of	  ATP-­‐induced	  PS	  exposure	  RBCs,	  from	  the	  
15	   individual	   donors,	   determined	   as	   the	   difference	   in	   the	   percentage	   of	   Annexin	   V+	   RBCs	  
following	  incubation	  in	  the	  presence	  and	  absence	  of	  ATP.	  
	  







